CAS: 29216-28-2; 10-(Quinuclidin-3-Ylmethyl)-10H-Phenothiazine

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号151129-13-4 dehydromequitazine | CAS号151129-15-6 (E)-10-(1-azabi... | CAS号92-84-2 吩噻嗪 | CAS号86014-80-4 3-(chloromethyl... | CAS号87-69-4 酒石酸 | CAS号40765-34-2 10-(1-azabicycl...

合成工艺路线路线简述

    Dehydromequitazine置于palladium 10% On Activated Carbon,氢气体系中,用 甲醇 用作溶剂,20.0 °C,101.33 Kpa 条件下,反应 24.0H,以91%的收率获得美喹他嗪
    参考文献:Expedient Synthesis Of Mequitazine An Antihistaminic Drug By Palladium Catalyzed Allylic Alkylation Of Sodium Phenothiazinate
    标题:Expedient Synthesis Of Mequitazine An Antihistaminic Drug By Palladium Catalyzed Allylic Alkylation Of Sodium Phenothiazinate
    摘要:报告了一种简短而直接的抗组胺药物美克替嗪的合成方法,该方法基于在温和条件下,采用钯催化的烯丙基烷基化反应,将1-氮杂双环[2.2.2]辛-2-烯-3-基乙酸甲酯与苯噻嗪钠进行反应.
    Doi:10.1248/cpb.57.1300

    海关参考信息

    专利信息


    专利号:US-8754074-B2
    优先权日:2011-01-10
    标题:Vinyl quinuclidine useful as a synthesis intermediate in the preparation of (R)-mequitazine
    发明人:NICOLAS MARC; LARQUETOUX LAURENT; LEROUX SÉBASTIEN; DORIS ERIC
    权利人:NICOLAS MARC; LARQUETOUX LAURENT; LEROUX SÉBASTIEN; DORIS ERIC; PF MEDICAMENT; COMMISSARIAT ENERGIE ATOMIQUE
    摘要:The present invention relates to the use of the vinyl quinuclidine enantiomer (R) of the following formula 2 as a synthesis intermediate in the preparation of (R)-mequitazine.

    专利号:US-8304545-B2
    优先权日:2007-01-18
    标 题:Quinuclidine derivative useful in the preparation of mequitazine
    发明人:MIOSKOWSKI CHARLES; GONNOT VANESSA; BAATI RACHID; NICOLAS MARC
    权利人:MIOSKOWSKI CHARLES; GONNOT VANESSA; BAATI RACHID; NICOLAS MARC; PF MEDICAMENT
    摘要:The invention relates to a 1-aza-bicyclo[2.2.2]oct-2-en-3-ylmethyl acetate of the formula (I), wherein said compound is useful as a synthesis intermediate for the production of mequitazine.

    专利号:US-2023271983-A1
    优先权日:2020-07-29
    标题 :Functionalized isonitriles and products, preparation and uses thereof
    发明人:SOTELO PÉREZ EDDY; AZUAJE GUERRERO JHONNY ALBERTO; MAJELLARO MARIA
    权利人:UNIV SANTIAGO COMPOSTELA
    摘要:The present invention relates to functionalized isonitrile compounds, formed by means of multicomponent environmentally friendly reactions, suitable for coupling to functional molecules such as biomolecules, APIs, chromophore and fluorophore molecules. The invention also relates to conjugates between said isonitrile compounds and functional molecules, which are useful in the synthesis of pharmaceutic drugs or tools, fluorescent molecules and labels, polymeric smart materials. The invention furthermore provides a kit for the in-vitro preparation of the functionalized isontrile compounds and conjugates. The invention also contemplates the medical use of said compounds and conjugates.

    专利号:EP-1037891-B1
    优先权日:1997-12-08
    标 题 :Method for preparing mequitazine and novel synthesis intermediate
    发明人:GUMINSKI YVES; IMBERT THIERRY; LESIMPLE PATRICK
    权利人:PF MEDICAMENT
    摘要:The invention concerns a novel method for preparing mequitazine and its laevo-gyrate isomer, consisting in reacting the phenothiazine derivative containing lithium with 3-methane sulphonyl oxymethyl-1-aza-bicyclo(2,2,2)-octane or its laevo-gyrate isomer, in the presence of butyllithium.

    专利号:FR-2777278-A1
    优先权日:1998-04-09
    标 题:NOVEL PROCESS FOR THE PREPARATION OF 3-HYDROXYMETHYL QUINUCLIDINE INTERMEDIATE SYNTHESIS OF MEQUITAZINE

    专利号:US-2006153882-A1
    优先权日:2001-05-29
    标题:Anti-allergic pharmaceutical composition containing at least one allergen and at least on antihistamine compound
    发明人:LORIA EMILE; TERRASSE GAETAN; TREHIN YVES
    权利人:LORIA EMILE; TERRASSE GAETAN; TREHIN YVES
    摘要:The present invention relates to an anti-allergic pharmaceutical composition containing at least two active agents chosen among: (i) one allergen, (ii) one antihistamine compound, (iii) one inhibitor of histamine synthesis, said active agents being associated in said composition with a pharmaceutically acceptable vehicle.
    宁波斯迈克制药有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.smart-pharm.com
    企业联系电话:0574-86221816👤
    📞宁波斯迈克制药有限公司 ⚠️参考联系方式
    联系人:张海波
    电话:0574-86221816
    手机:13957841334
    传真:0574-86222227
    邮箱:smart@smart-pharm.com;carolyn@smart-pharm.com
    通信地址: 浙江省宁波市北仑区小港镇义成路1号
    邮编: 315803
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:浙江省宁波市北仑区小港镇义成路1号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    湖北威德利化学科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.widelychemical.com
    企业联系电话:13385289472👤
    📞湖北威德利化学科技有限公司 ⚠️参考联系方式
    联系人:赵方
    电话:13385289472
    手机:13385289472
    传真:027- 59222918
    邮箱:z13385289472@163.com
    通信地址: 湖北省武汉市硚口区解放大道204号
    邮编: 430033
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:湖北省武汉市硚口区解放大道204号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Ahn SH, Maeng HJ. Quantification of mequitazine in human plasma by gas chromatography- quadrupole mass spectrometry and its application to a human pharmacokinetic study. Biomed Chromatogr. 2016 Apr;30(4):574-8. doi: 10.1002/bmc.3585. Epub 2015 Sep 20. doi: 10.1021/ol2012567. Epub 2011 Jun 9. doi: 10.1016/j.saa.2009.08.006. Epub 2009 Aug 12. doi: 10.1016/j.talanta.2006.02.059. Epub 2006 May 2. Review. Spanish. Spanish.
    9: Kwon OS, Kim HJ, Pyo H, Chung SJ, Chung YB. Determination of mequitazine in human plasma by gas-chromatography/mass spectrometry with ion-trap detector and its pharmacokinetics after oral administration to volunteers. Arch Pharm Res. 2005 Oct;28(10):1190-5. Russian. French. Bulgarian. Japanese.

    合成参考文献


    参考文献:10.1007/bf00186167
    摘要:Matsumoto S, Yamasaki M, Kanno T, Nagayama T, Tanno M, Shimizu T. Substance P antagonist does not block the stimulation of rapidly adapting pulmonary stretch receptors by ammonia. Lung. 1994;172(1):31–45. doi: 10.1007/bf00186167.
    参考文献:10.2165/00003495-199346060-00008
    摘要:Spencer CM, Faulds D, Peters DH. Cetirizine. A reappraisal of its pharmacological properties and therapeutic use in selected allergic disorders. Drugs. 1993 Dec;46(6):1055–80. doi: 10.2165/00003495-199346060-00008.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知